Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 3Breast 3Tumor-Agnostic 2Thoracic 2Gastrointestinal 2Other 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 2

Interventions

Carboplatin 347pembrolizumab 322Pemetrexed 246Cisplatin 218Paclitaxel 147Nivolumab 138durvalumab 133osimertinib 112Docetaxel 111atezolizumab 109Specimen Handling 91Radiotherapy 87Drug Therapy 85Magnetic Resonance Spectroscopy 77Etoposide 76Radiosurgery 72Gemcitabine 71Ipilimumab 55130-nm albumin-bound paclitaxel 54Bevacizumab 52cemiplimab 47tislelizumab 44Blood Specimen Collection 40Cetuximab 35Taxes 34Platinum 33Injections 33Biopsy 33Standard of Care 31Immunoglobulin G 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Electroacupuncture × Thoracic × 1 year × Clear all
NCT07239661 2025-11-20

Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Phase NA Recruiting
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07086300 2025-07-25

Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Phase NA Recruiting
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡